Clinical trial
Evaluation of Clinical and Imaging Criteria, and Plasma Biomarkers of Patients Receiving an Endovascular Treatment for an Acute Ischemic Stroke
NCT03776877 is registered in ClinicalTrials.gov with Hopital Foch as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Clinical and Imaging Criteria, and Plasma Biomarkers of Patients Receiving an Endovascular Treatment for an Acute Ischemic Stroke
- Lead sponsor
- Hopital Foch
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 26, 2018
- Completion date
- December 31, 2022
- Enrollment
- 4,000 (estimated)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
stroke, acute